|
Nephrology Hypertension Journal Club-Recovery From Dialysis-Treated Acute Injury in Patients With Cirrhosis: A Population-Based Study - May 27, 2022 |
05/27/2022 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club -Treatment for Mild Chronic Hypertension during Pregnancy - June 3, 2022 |
06/03/2022 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club - Fracture Risk of Sodium - Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease - June 17, 2022 |
06/17/2022 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club-Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial - June 24, 2022 |
06/24/2022 - 7:30am to 8:30am |
|
CANCELLED - Nephrology Hypertension Journal Club, July 1, 2022 |
07/01/2022 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club-Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy-June 8, 2022 |
07/08/2022 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club - Restriction of Intravenous Fluid in ICU Patients with Septic Shock - July 15, 2022 |
07/15/2022 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club - Timing of Dialysis Initiation to Reduce Mortality and Cardiovascular in Advanced Chronic Kidney Disease - July 22, 2022 |
07/22/2022 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club - Effectiveness and Safety of Apixaban versus Warfarin in VTE Patients with CKD - July 29, 2022 |
07/29/2022 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club-Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responses-August 5, 2022 |
08/05/2022 - 7:30am to 8:30am |
Facebook
X
LinkedIn
Forward